How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Colorectal Cancer

Select Clinical Trial

Colorectal Cancer

Protocol Number: NRG GI004

Protocol Title: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer

Eligibility: Men or women, ages 18 and older, diagnosed with Deficient DNA Mismatch repair metastatic colorectal cancer

Contact Information: (910) 715-2200

__________________________________________________________________________________________

Protocol Number: Alliance A021703

Protocol Title: Randomized double-blinded phase III trial of high-dose vs. standard dose of vitamin D3 in patients with previously untreated metastatic colorectal cancer.

Eligibility:  Men and women, ages 18 and older with locally advanced/metastatic colorectal adenocarcinomas that have had no prior treatment for metastatic disease.

Contact Information: (910) 715-2200

Specialties
Clara McLean House
Make a Donation
News & Events